Home/Laigo Bio/Qi Liang

QL

Qi Liang

CDO

Therapeutic Areas

Oncology Auto-immunity

Laigo Bio Pipeline

Drug	Indication	Phase
Oncology Programs	Novel IO targets & intractable oncogenic drivers	Preclinical
Auto-immunity Programs	Autoimmune disease & graft rejection	Preclinical

Leadership Team at Laigo Bio

Neill Moray Mackenzie

Co-founder & Chair

Madelon Maurice

Scientific founder

Richard Sainson

Director of Operations

View full Laigo Bio profile